Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Najla H, Al Ali"'
Autor:
Somedeb Ball, Najla H. Al Ali, Akriti G. Jain, Luis E. Aguirre, Seongseok Yun, Onyee Chan, Zhuoer Xie, David A. Sallman, Jeffrey Lancet, Eric Padron, Rami S. Komrokji, Andrew T. Kuykendall
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
BackgroundDisease related anemia in myelofibrosis (MF) is common and prognostically detrimental. Anemia in MF poses a therapeutic challenge as it contributes to poor quality of life and often interferes with JAK inhibitor therapy. Still, the causes f
Externí odkaz:
https://doaj.org/article/9cf363a3a5d945369cb9d94442550bad
Autor:
Abhishek A. Mangaonkar, Terra L. Lasho, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat, Aref Al-Kali, Kebede H. Begna, Animesh Pardanani, Najla H. Al Ali, Chetasi Talati, David Sallman, Eric Padron, Mrinal M. Patnaik, Ayalew Tefferi, Rami Komrokji
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-6 (2022)
Abstract The current World Health Organization (WHO) classification of myeloid malignancies includes myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) as a distinct entity. Previous literature on pr
Externí odkaz:
https://doaj.org/article/8153cb3623324da3b83edb09eee43e17
Autor:
Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour, David Sallman, Anthony Michael Hunter, Christopher Benton, Kelly S. Chien, Rajyalakshmi Luthra, Carlos E. Bueso-Ramos, Tapan Kadia, Michael Andreeff, Rami S. Komrokji, Najla H Al Ali, Nicholas Short, Naval Daver, Mark J. Routbort, Joseph D. Khoury, Keyur Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly A. Soltysiak, Olivier Lichtarge, L. Jeffrey Medeiros, Hagop Kantarjian, Guillermo Garcia-Manero
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/d441753451c843299b7592b75c6d1078
Autor:
Rami S. Komrokji, Najla H Al Ali, David Sallman, Eric Padron, Amy E. DeZern, John Barnard, Gail J. Roboz, Guillermo Garcia‐Manero, Alan List, David P. Steensma, Mikkael A. Sekeres
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 447-453 (2021)
Abstract The utility of the International Working Group (IWG) 2006 response criteria for myelodysplastic syndromes (MDS) as a surrogate endpoint for outcomes is unclear. We assessed the validity of the IWG 2006 response criteria in a large cohort of
Externí odkaz:
https://doaj.org/article/1d34c146c220412f989baad701ef977a
Autor:
Abhishek A. Mangaonkar, Terra L. Lasho, Christy Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough, Naseema Gangat, Aref Al-Kali, Kebede H. Begna, William H. Hogan, Mark R. Litzow, Hassan Alkhateeb, Mithun Shah, Animesh Pardanani, Ayalew Tefferi, Najla H. Al Ali, Chetasi Talati, David Sallman, Eric Padron, Rami Komrokji, Mrinal M. Patnaik
Publikováno v:
Haematologica, Vol 107, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/058bd801e0344842925958441b67cbc2
Autor:
Naseema Gangat, Andrew T Kuykendall, Najla H Al Ali, Swati Goel, Maymona Abdelmagid, Aref Al-Kali, Hassan B Alkhateeb, Kebede Begna, Abhishek A. Mangaonkar, Mark R Litzow, William J Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh D Pardanani, Rami S. Komrokji, Ayalew Tefferi
Publikováno v:
Blood Advances.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0466a4a1f98f95c3bab1ad31d180701
https://doi.org/10.1182/bloodadvances.2022009611
https://doi.org/10.1182/bloodadvances.2022009611
Autor:
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G. Abdelmagid, Aref Al‐Kali, Michelle A. Elliott, Kebede H. Begna, James M. Foran, Talha Badar, Nandita Khera, Najla H. Al Ali, Eric Padron, David A. Sallman, Mithun Shah, Devendra Hiwase, Animesh Pardanani, Daniel A. Arber, Attilio Orazi, Kaaren K. Reichard, Rong He, Rhett P. Ketterling, Naseema Gangat, Rami Komrokji, Ayalew Tefferi
Publikováno v:
American Journal of Hematology. 98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e7f0f045506d48da3f5f28b14536fc0
https://doi.org/10.1002/ajh.26845
https://doi.org/10.1002/ajh.26845
Autor:
Catherine C. Coombs, David A. Sallman, Sean M. Devlin, Shweta Dixit, Abhinita Mohanty, Kristina Knapp, Najla H. Al Ali, Jeffrey E. Lancet, Alan F. List, Rami S. Komrokji, Eric Padron, Maria E. Arcila, Virginia M. Klimek, Marcel R. M. van den Brink, Martin S. Tallman, Ross L. Levine, Raajit K. Rampal, Franck Rapaport
Publikováno v:
Haematologica, Vol 101, Iss 11 (2016)
Externí odkaz:
https://doaj.org/article/164d8500288c4318ae19e0d3e8421161
Autor:
Kathy L. McGraw, Johnny Nguyen, Rami S. Komrokji, David Sallman, Najla H. Al Ali, Eric Padron, Jeffrey E. Lancet, Lynn C. Moscinski, Alan F. List, Ling Zhang
Publikováno v:
Haematologica, Vol 101, Iss 8 (2016)
Externí odkaz:
https://doaj.org/article/5fb82e67babe49b4976bdd4b16a1a3ab
Autor:
David A, Sallman, Amy E, DeZern, Guillermo, Garcia-Manero, David P, Steensma, Gail J, Roboz, Mikkael A, Sekeres, Thomas, Cluzeau, Kendra L, Sweet, Amy, McLemore, Kathy L, McGraw, John, Puskas, Ling, Zhang, Jiqiang, Yao, Qianxing, Mo, Lisa, Nardelli, Najla H, Al Ali, Eric, Padron, Greg, Korbel, Eyal C, Attar, Hagop M, Kantarjian, Jeffrey E, Lancet, Pierre, Fenaux, Alan F, List, Rami S, Komrokji
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(14)
Approximately 20% of patients withThis was a phase Ib/II study to determine the safety, recommended phase II dose, and efficacy of eprenetapopt administered in combination with azacitidine in patients withFifty-five patients (40 MDS, 11 AML, and four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::691b6c8aac02600499f5a6e3cc2f0335
https://pubmed.ncbi.nlm.nih.gov/33449813
https://pubmed.ncbi.nlm.nih.gov/33449813